Hi Investor ๐Ÿ‘‹ SILICON VALLEY, USA ยท FEMTECH ยท MEDICALLY POWERED AI

Medically powered.
AI enabled.
Never offline.

NuMaa.ai is a medically powered, AI-enabled pregnancy companion, US-headquartered and built by a Silicon Valley technologist and a practicing OB-GYN. Every answer is medically validated; AI is the delivery layer, not the source of truth, closing the gap between doctor visits in the moments that matter most.

140M
pregnancies worldwide, every year
26M
annual pregnancies in India alone
$60B+
global femtech market by 2030
12
specialized AI agents, one companion
THE PROBLEM

The "First Delay" is the #1 preventable risk in pregnancy.

Between scheduled OB-GYN visits, mothers are on their own, and the gap is where danger signs get missed and false reassurance gets believed.

48.6%
Delayed care from false advice
Nearly half of delayed care decisions trace back to inaccurate information, not lack of concern.
31.2%
Missed danger signs
Warning signs go unrecognized without a trusted, always-available filter.
58%
Complete under 4 ANC visits
Only a majority-minus complete the WHO-recommended minimum antenatal care visits.
88
Maternal deaths / 100K births
Most complications behind this figure are preventable with timely action.
The biggest challenge in pregnancy isn't medical knowledge, it's uncertainty, loneliness, and fear in the 99% of the week no doctor is watching.
THE PRODUCT

Meet Ask NuMaa: medically powered, AI enabled, live 24/7.

Not a chatbot bolted onto a tracker. Every answer is medically validated, AI is how it's delivered, not where it comes from. Ask NuMaa greets a mother by her pregnancy week, asks the right clinical questions, and knows when to reassure, and when to escalate. Step through a real scenario below.

REAL-WORLD SCENARIO

Early Morning Anxiety

6:30 AM. Mild abdominal tightness and a headache. Her next appointment is 10 days away. Watch what happens instead of a 2-hour Google spiral.

โœ“ Outcome: calm, reassured, and guided, not panicked and spiraling.
Ask NuMaa yourself โ†’ numaa.ai
๐Ÿฉบ
Medical Triaging
Symptom triage, red-flag detection, medication safety, and doctor-visit prep, every threshold authored by a licensed OB-GYN, with seamless handoff to a clinician when it matters.
๐Ÿฅ—
Diet & Nutrition
Trimester-aware meal guidance, wellness and movement support, and milestone tracking, medically grounded, not generic wellness content.
๐Ÿ’›
Companion Awareness
Mental health check-ins, night support for late-night fears, and family harmony guidance, present at 6:30 AM and 11:45 PM alike, never offline.
All three pillars are powered by 12 specialized agents working in concert, one companion, medically validated end to end.
WHY NUMAA, WHY NOW

Femtech capital rewards clinical credibility. We're built with it in, not bolted on.

Investors in this category increasingly fund companies with physician-led care, not just AI branding. That's the gap most competitors can't close, and the one NuMaa starts with.

Founder-Market Fit

A rare founding pair

A Silicon Valley AI technologist and a UK/India/ME-trained Consultant OB-GYN, co-founding together, not an advisor bolted on after the fact. This is the single hardest thing for a competitor to replicate quickly.

Architecture

Multi-agent, hyper-personalized

Twelve specialized agents with contextual handoff, not a single chatbot with a pregnancy skin. Purpose-built models trained on pregnancy-specific medical data, with RAG that hyper-personalizes to each mother's history over time.

Clinical Safety

Escalation is the default

Every red-flag pathway routes to a licensed OB-GYN, authored and reviewed under Dr. Bindiya's clinical protocols, not a generic disclaimer at the bottom of a chat window.

Distribution

India-first, not India-only

26M annual pregnancies in one country, the largest single-market opportunity globally, with a trust-first GTM anchored in hospital and OB-GYN referral relationships, not paid acquisition alone.

MARKET OPPORTUNITY

A large, recurring market, segmented three ways.

Femtech isn't one market. NuMaa sits at the intersection of consumer subscription, B2B healthcare distribution, and payer-funded wellness, reducing dependence on any single channel.

140M
Annual pregnancies, globally
A naturally renewing, large-scale addressable market, every year, a fresh cohort of high-intent users.
26M
Annual pregnancies in India
The world's largest single-country opportunity, with rising smartphone penetration and health awareness.
9mo+
Primary engagement window
Extends through postpartum and future pregnancies, long lifecycle value per acquired user.
B2B
Hospital & clinic partnerships
White-label and co-branded deployments for maternity hospitals and OB-GYN networks, Dr. Bindiya's clinical network is the wedge.
EMR
Integration pathway
Phase 2 roadmap: EMR integration for hospital systems, turning NuMaa into infrastructure, not just an app.
Referral
Trust-first acquisition
Physician-championed referral is the highest-converting channel in maternal health, and the hardest for a pure consumer app to buy.
$60B+
Global femtech market by 2030
Positioned at the intersection of femtech, digital health, and consumer subscription, three converging categories.
Corp.
Employer wellness programs
Maternal benefits are an increasingly common corporate wellness line item, especially in urban India and diaspora markets.
Payer
Outcomes-based pricing
Insurers pay for reduced complication rates, the same logic that has driven US maternal-health payer deals.
Figures as provided by NuMaa.ai; independent verification against primary market-research sources recommended before external investor use.
BUSINESS MODEL

Six revenue streams across the pregnancy lifecycle.

Premium Subscription (B2C)
Tiered monthly/annual plans for expecting mothers.
Hospital & Clinic Partnerships
White-label deployments for maternity networks.
Insurance & Employer Wellness
Outcomes-based corporate and payer programs.
Doctor Consultation Marketplace
Commission on verified OB-GYN bookings.
Brand Partnerships & Commerce
Curated nutrition and baby-product affiliate revenue.
Healthcare Data Insights
Anonymized, privacy-safe insights for research and payer partners.
ROADMAP

From AI companion to global motherhood platform.

PHASE 1
AI Pregnancy Companion
Core Ask NuMaa companion live, nutrition, fitness, mental health. Clinical validation partnerships in India metros.
PHASE 2
Hospital Integrations
White-label B2B for maternity hospitals. EMR integration. Insurance and employer wellness programs launch.
PHASE 3
Postpartum & Baby Care
Newborn care guidance, postpartum mental health, breastfeeding coaching, pediatric development tracking.
PHASE 4
Global Motherhood Platform
Scale to Southeast Asia, Middle East, UK, and North American diaspora. Launch data-insights business line.
THE TEAM

Silicon Valley AI expertise, paired with clinical authority.

Praveen Dulam
Co-Founder & CEO

Silicon Valley technology entrepreneur with 20+ years building large-scale platforms across AI, GenAI, cloud, data, and enterprise systems. Former engineering and product leader at Google, Meta, Apple, and Cisco. Adjunct professor at Northeastern University. MS and MBA, Columbia University and London Business School.

Book 20 min โ†’
Dr. Bindiya Jhamb
Co-Founder & Chief Medical Officer

Internationally trained Consultant Obstetrician & Gynaecologist, with clinical training and practice spanning the UK, India, and the Middle East (MRCOG, CCT UK), and 20+ years of global clinical experience in pregnancy care. Currently a practicing Consultant and Divisional Head. MRCOG examiner and Executive MBA, London Business School. Owns clinical protocol design and every escalation pathway in the product.

Book 20 min โ†’
"An exceptionally rare founding pair for this category: deep Silicon Valley AI expertise matched with world-class obstetric clinical authority in the same founding team, not split across a founder and an advisor."
ADVISORY BOARD

Strategic counsel for capital, platform, and scale.

Miten Mehta
Advisor ยท Board Director & Strategic Advisor, AI Platform & Partnerships

30+ years as a C-suite operator across AI, FinTech, SaaS, Cloud, and Marketplace businesses spanning the US, UK, India, MENA, and APAC. Track record includes $760M+ capital raised, 3 IPOs at $1B+, and $2B+ in exits, with senior roles at Mondee/Tabhi.ai, Fractal Analytics, Google Cloud, Financial Technologies India, and Qualcomm. Advises NuMaa on AI platform strategy, institutional and sovereign capital relationships, and go-to-market partnership design.

$760M+
Capital Raised
3
IPOs @ $1B+
$2B+
Exits
30+
Years C-Suite
TRUST & COMPLIANCE

Built for regulated healthcare data, from day one.

Maternal health data is among the most sensitive categories that exists. NuMaa's architecture and governance are designed around that reality, not retrofitted to it.

HIPAA-Aligned Architecture
End-to-end encryption and access controls designed against HIPAA technical safeguards, ahead of any future US market entry.
India DPDP Act, 2023
India's Digital Personal Data Protection Act governs the primary launch market, consent-first data handling by design.
UAE Data Protection Law
Corporate structure and data governance aligned to UAE Federal PDPL / DIFC data protection requirements.
Physician-Governed Escalation
Every clinical protocol and red-flag threshold is authored and reviewed by a practicing, licensed OB-GYN, not a generic AI disclaimer.
THE ASK

Raising $100,000 to build the infrastructure for safe pregnancies.

$100,000
Amount Raising
$1,000,000
Pre-Money Valuation
9.1%
Investor Equity ($1.1M post-money)
30%
Engineering & Product
20%
Go-To-Market
20%
Operations & Compliance
30%
Growth & Reserve
First-close target: 10,000 active users across 5 metro cities and a live OB-GYN referral network by Month 3, the milestone this $100,000 is priced to reach.